NanoVibronix, Inc. (NASDAQ:NAOV) Sees Significant Decrease in Short Interest

NanoVibronix, Inc. (NASDAQ:NAOV) was the recipient of a significant decline in short interest in the month of December. As of December 31st, there was short interest totalling 249,900 shares, a decline of 58.0% from the December 15th total of 594,600 shares. Based on an average trading volume of 1,380,000 shares, the short-interest ratio is presently 0.2 days. Approximately 6.7% of the company’s shares are short sold.

NanoVibronix Stock Down 3.5 %

Shares of NAOV stock traded down $0.02 during mid-day trading on Monday, reaching $0.50. The company’s stock had a trading volume of 325,123 shares, compared to its average volume of 9,272,259. The firm has a market capitalization of $1.87 million, a PE ratio of -0.40 and a beta of 1.64. The company’s 50 day simple moving average is $0.64 and its 200-day simple moving average is $0.64. NanoVibronix has a 12-month low of $0.46 and a 12-month high of $1.52.

NanoVibronix Company Profile

NanoVibronix, Inc, through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use.